Long-term outcomes and prognostic factors for neuroendocrine G1 and G2 lung tumors

J. Wälscher, G. Weinreich, D. Theegarten, S. Ting, A. Tannapfel, G. Stamatis (Essen, Bochum, Germany)

Source: Annual Congress 2012 - Prognosis of lung cancer
Session: Prognosis of lung cancer
Session type: Thematic Poster Session
Number: 4177
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Wälscher, G. Weinreich, D. Theegarten, S. Ting, A. Tannapfel, G. Stamatis (Essen, Bochum, Germany). Long-term outcomes and prognostic factors for neuroendocrine G1 and G2 lung tumors. Eur Respir J 2012; 40: Suppl. 56, 4177

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effects of prognostic factors on survival of the patients of non-small cell lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 326s
Year: 2005

Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 385s
Year: 2006

Assessing the relevance of biological prognostic indices in predicting survival in non-small cell lung cancer
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017


Effects of pretreatment prognostic factors and treatment on survival in advanced nonsmall cell lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 431s
Year: 2003

Prognostic factors affecting survival in advanced non-small cell lung cancer patients
Source: Eur Respir J 2004; 24: Suppl. 48, 75s
Year: 2004

Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer
Source: Eur Respir J 2007; 30: Suppl. 51, 669s
Year: 2007

The expression of central cell cycle regulators in non-small cell lung cancer has therapy-dependent prognostic impact
Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease
Year: 2012

Clinicopathological prognostic factors in operated for lung cancer and brain metastasis patients
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017


Interleukine-17A implicated in survival outcome of patients with late stage lung adenocarcinoma
Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Year: 2018

Clinical factors of long-term survival in patients with advanced lung cancer
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017

The predictive value of neuroendocrine markers for response to chemotherapy and survival in patients with non-small cell lung
Source: Eur Respir J 2006; 28: Suppl. 50, 386s
Year: 2006

Survival and clinico-pathologic prognostic factors in surgically resected non-small cell lung carcinoma
Source: Eur Respir J 2006; 28: Suppl. 50, 751s
Year: 2006

The impact of neuroendocrine differentiation in the prognosis of non-small cell lung cancer
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012

Survival and prognostic factors of oligometastatic non-small cell lung carcinoma: A single center experience
Source: International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons
Year: 2017

Analysis of surgical stage lung cancer and tumour markers prognostic value
Source: Eur Respir J 2006; 28: Suppl. 50, 770s
Year: 2006

Bcl-2 as a prognostic factor for survival in small-cell lung cancer
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009

Brain metastasis as initial presentation of lung cancer - Impact of prognostic factors on patient survival
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017

Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer
Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Year: 2008